Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions
Aurora 激酶抑制剂在 G2/M 检查点缺陷型 TP53 突变型子宫癌中的疗效增强与 LKB1-AKT-p53 相互作用的总和有关
期刊:Cancers
影响因子:
doi:10.3390/cancers13092195
Katherine N Lynch, Joyce F Liu, Nikolas Kesten, Kin-Hoe Chow, Aniket Shetty, Ruiyang He, Mosammat Faria Afreen, Liping Yuan, Ursula A Matulonis, Whitfield B Growdon, Michael G Muto, Neil S Horowitz, Colleen M Feltmate, Michael J Worley Jr, Ross S Berkowitz, Christopher P Crum, Bo R Rueda, Sarah J Hi